Square Pharmaceuticals Ltd. declared Cash Dividend @ 100% to its Shareholders for the year ended 30 June, 2022 at its 56th Annual General Meeting held under the virtual platform on Saturday the 24th December, 2022.
The AGM was presided over by the Chairman of the Company Mr. Samuel S Chowdhury.
Mrs. Ratna Patra, Vice Chairman; Mr. Tapan Chowdhury, Managing Director, Mr. Kazi Iqbal Harun, Director, Mr. Syed Afzal Hasan Uddin and Mr. S.M. Rezaur Rahman, Independent Director, Mr. Md. Kabir Reza, Head of A&F, Mr. Md. Zahangir Alam, Chief Financial Officer and Mr. Khandaker Habibuzzaman, Company Secretary attended the meeting.
The Turnover, Gross Profit and Net Profit (After Tax) for the year ended 30 June, 2022 were Tk. 6,641 crore, Tk. 2,964 crore and Tk. 1,818 crore respectively. Turnover and Net Profit rises to 13.81% and 13.98% respectively during the year under review.
The company contributed an amount of Tk. 1,472 crore to the National Exchequer.
The Board of Directors appreciates the performance of the officers, staff and workers whose untiring efforts helped to optimize the profit of the Company. The Directors expressed their gratitude and acknowledged with keen interest the co-operation and unflinching support received from various agencies including Bangladesh Securities and Exchange Commission, Stock Exchanges, National Board of Revenue and other agencies of the public and private sector.
Shareholders attended the AGM and many of them took part in the discussion regarding the company’s performance and future expansion. At the end Mr. Samuel S Chowdhury, Chairman expressed their deep appreciation to shareholders for their trust and support to the company’s performance.